{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:58:23Z","timestamp":1793314703313,"version":"4.5.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Migraine is a ubiquitous neurologic disease that afflicts people of all ages. Its molecular pathogenesis involves peptides that promote intracranial vasodilation and modulate nociceptive transmission upon release from sensory afferents of cells in the trigeminal ganglion and parasympathetic efferents of cells in the sphenopalatine ganglion. Experimental data have confirmed that intravenous infusion of these vasoactive peptides induce migraine attacks in people with migraine, but it remains a point of scientific contention whether their site of action lies outside or within the central nervous system. In this context, it has been hypothesized that transient dysfunction of brain barriers before or during migraine attacks might facilitate the passage of migraine-inducing peptides into the central nervous system. Here, we review evidence suggestive of brain barrier dysfunction in migraine pathogenesis and conclude with lessons learned in order to provide directions for future research efforts.<\/jats:p>","DOI":"10.1186\/s10194-021-01365-w","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T14:03:43Z","timestamp":1643205823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Brain barriers and their potential role in migraine pathophysiology"],"prefix":"10.1186","volume":"23","author":[{"given":"Astrid","family":"Wiggers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e5kan","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouchine","family":"Hadjikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Sagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berislav V.","family":"Zlokovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lauritzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"issue":"19","key":"1365_CR1","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1056\/NEJMra1915327","volume":"383","author":"M Ashina","year":"2020","unstructured":"Ashina M, Ropper AH (2020) Migraine. N Engl J Med 383(19):1866\u20131876. https:\/\/doi.org\/10.1056\/NEJMra1915327","journal-title":"N Engl J Med"},{"issue":"2","key":"1365_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ana.410160202","volume":"16","author":"MA Moskowitz","year":"1984","unstructured":"Moskowitz MA (1984) The neurobiology of vascular head pain. Ann Neurol 16(2):157\u2013168. https:\/\/doi.org\/10.1002\/ana.410160202","journal-title":"Ann Neurol"},{"issue":"8","key":"1365_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/s1474-4422(19)30185-1","volume":"18","author":"M Ashina","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA (2019) Migraine and the trigeminovascular system\u201440 years and counting. Lancet Neurol 18(8):795\u2013804. https:\/\/doi.org\/10.1016\/s1474-4422(19)30185-1","journal-title":"Lancet Neurol"},{"issue":"12","key":"1365_CR4","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrneurol.2017.137","volume":"13","author":"M Ashina","year":"2017","unstructured":"Ashina M, Hansen JM, BO AD, Olesen J. (2017) Human models of migraine - short-term pain for long-term gain. Nat Rev Neurol 13(12):713\u2013724. https:\/\/doi.org\/10.1038\/nrneurol.2017.137","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"1365_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd.2015.21","volume":"15","author":"WA Banks","year":"2016","unstructured":"Banks WA (2016) From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 15(4):275\u2013292. https:\/\/doi.org\/10.1038\/nrd.2015.21","journal-title":"Nat Rev Drug Discov"},{"issue":"23","key":"1365_CR6","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1113\/JP275376","volume":"596","author":"NR Saunders","year":"2018","unstructured":"Saunders NR, Dziegielewska KM, M\u00f8llg\u00e5rd K, Habgood MD (2018) Physiology and molecular biology of barrier mechanisms in the fetal and neonatal brain. J Physiol 596(23):5723\u20135756. https:\/\/doi.org\/10.1113\/JP275376","journal-title":"J Physiol"},{"issue":"40","key":"1365_CR7","doi-asserted-by":"publisher","first-page":"E9429","DOI":"10.1073\/pnas.1802155115","volume":"115","author":"N Kutuzov","year":"2018","unstructured":"Kutuzov N, Flyvbjerg H, Lauritzen M (2018) Contributions of the glycocalyx, endothelium, and extravascular compartment to the blood\u2013brain barrier. Proc Natl Acad Sci U S A 115(40):E9429\u2013E9438. https:\/\/doi.org\/10.1073\/pnas.1802155115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1365_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.1993.73.3.489","volume":"73","author":"A Ermisch","year":"1993","unstructured":"Ermisch A, Brust P, Kretzschmar R, R\u00fchle HJ (1993) Peptides and blood-brain barrier transport. Physiol Rev 73(3):489\u2013527. https:\/\/doi.org\/10.1152\/physrev.1993.73.3.489","journal-title":"Physiol Rev"},{"issue":"8020","key":"1365_CR9","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/s0140-6736(77)91262-4","volume":"1","author":"AM Harper","year":"1977","unstructured":"Harper AM, MacKenzie ET, McCulloch J, Pickard JD (1977) Migraine and the blood-brain barrier. Lancet. 1(8020):1034\u20131036. https:\/\/doi.org\/10.1016\/s0140-6736(77)91262-4","journal-title":"Lancet."},{"issue":"9","key":"1365_CR10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/ene.13341","volume":"24","author":"FM Amin","year":"2017","unstructured":"Amin FM, Hougaard A, Cramer SP, Christensen CE, Wolfram F, Larsson HBW, Ashina M (2017) Intact blood-brain barrier during spontaneous attacks of migraine without aura: a 3T DCE-MRI study. Eur J Neurol 24(9):1116\u20131124. https:\/\/doi.org\/10.1111\/ene.13341","journal-title":"Eur J Neurol"},{"issue":"6","key":"1365_CR11","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/brain\/awx089","volume":"140","author":"A Hougaard","year":"2017","unstructured":"Hougaard A, Amin FM, Christensen CE, Younis S, Wolfram F, Cramer SP, Larsson HBW, Ashina M (2017) Increased brainstem perfusion, but no blood-brain barrier disruption, during attacks of migraine with aura. Brain. 140(6):1633\u20131642. https:\/\/doi.org\/10.1093\/brain\/awx089","journal-title":"Brain."},{"issue":"3","key":"1365_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1148\/radiol.2019182566","volume":"292","author":"YS Kim","year":"2019","unstructured":"Kim YS, Kim M, Choi SH, You SH, Yoo RE, Kang KM, Yun TJ, Lee ST, Moon J, Shin YW (2019) Altered vascular permeability in migraine-associated brain regions: evaluation with dynamic contrastenhanced MRI. Radiology. 292(3):713\u2013720. https:\/\/doi.org\/10.1148\/radiol.2019182566","journal-title":"Radiology."},{"issue":"Pt 7","key":"1365_CR13","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1093\/brain\/aww096","volume":"139","author":"CJ Schankin","year":"2016","unstructured":"Schankin CJ, Maniyar FH, Seo Y, Kori S, Eller M, Chou DE, Blecha J, Murphy ST, Hawkins RA, Sprenger T, VanBrocklin HF, Goadsby PJ (2016) Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine. Brain. 139(Pt 7):1994\u20132001. https:\/\/doi.org\/10.1093\/brain\/aww096","journal-title":"Brain."},{"issue":"5","key":"1365_CR14","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/j.1526-4610.2006.00641.x","volume":"47","author":"R Leira","year":"2007","unstructured":"Leira R, Sobrino T, Rodr\u00edguez-Y\u00e1\u00f1ez M, Blanco M, Arias S, Castillo J (2007) MMP-9 immunoreactivity in acute migraine. Headache. 47(5):698\u2013702. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00641.x","journal-title":"Headache."},{"issue":"1","key":"1365_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1526-4610.2007.00958.x","volume":"48","author":"K Imamura","year":"2008","unstructured":"Imamura K, Takeshima T, Fusayasu E, Nakashima K (2008) Increased plasma matrix metalloproteinase-9 levels in migraineurs. Headache. 48(1):135\u2013139. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00958.x","journal-title":"Headache."},{"issue":"1","key":"1365_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1468-1331.1994.tb00053.x","volume":"1","author":"LL Thomsen","year":"1994","unstructured":"Thomsen LL, Kruuse C, Iversen HK, Olesen J (1994) A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1(1):73\u201380. https:\/\/doi.org\/10.1111\/j.1468-1331.1994.tb00053.x","journal-title":"Eur J Neurol"},{"issue":"1\u20132","key":"1365_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0006-8993(00)03294-7","volume":"893","author":"GA Rosenberg","year":"2001","unstructured":"Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, Grossetete M, Razhagi A, Miller K, Gearing A (2001) Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893(1\u20132):104\u2013112. https:\/\/doi.org\/10.1016\/S0006-8993(00)03294-7","journal-title":"Brain Res"},{"issue":"10","key":"1365_CR18","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1172\/jci21227","volume":"113","author":"Y Gursoy-Ozdemir","year":"2004","unstructured":"Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H, Wang X, Rosenberg GA, Lo EH, Moskowitz MA (2004) Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113(10):1447\u20131455. https:\/\/doi.org\/10.1172\/jci21227","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"1365_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.cca.2009.07.008","volume":"408","author":"A Martins-Oliveira","year":"2009","unstructured":"Martins-Oliveira A, Speciali JG, Dach F, Marcaccini AM, Gon\u00e7alves FM, Gerlach RF, Tanus-Santos JE (2009) Different circulating metalloproteinases profiles in women with migraine with and without aura. Clin Chim Acta 408(1\u20132):60\u201364. https:\/\/doi.org\/10.1016\/j.cca.2009.07.008","journal-title":"Clin Chim Acta"},{"issue":"3","key":"1365_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1468-2982.2009.01954.x","volume":"30","author":"M Ashina","year":"2010","unstructured":"Ashina M, Tvedskov JF, Lipka K, Bilello J, Penkowa M, Olesen J (2010) Matrix metalloproteinases during and outside of migraine attacks without aura. Cephalalgia. 30(3):303\u2013310. https:\/\/doi.org\/10.1111\/j.1468-2982.2009.01954.x","journal-title":"Cephalalgia."},{"issue":"4","key":"1365_CR21","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/jnr.20387","volume":"79","author":"M Penkowa","year":"2005","unstructured":"Penkowa M, Florit S, Giralt M, Quintana A, Molinero A, Carrasco J, Hidalgo J (2005) Metallothionein reduces central nervous system inflammation, neurodegeneration, and cell death following kainic acid-induced epileptic seizures. J Neurosci Res 79(4):522\u2013534. https:\/\/doi.org\/10.1002\/jnr.20387","journal-title":"J Neurosci Res"},{"issue":"1","key":"1365_CR22","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/0300060513488514","volume":"42","author":"M Li","year":"2014","unstructured":"Li M, Yang G, Xie B, Babu K, Huang C (2014) Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation. J Int Med Res 42(1):224\u2013230. https:\/\/doi.org\/10.1177\/0300060513488514","journal-title":"J Int Med Res"},{"issue":"2","key":"1365_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/clin.1996.0025","volume":"78","author":"BL Gruber","year":"1996","unstructured":"Gruber BL, Sorbi D, French DL, Marchese MJ, Nuovo GJ, Kew RR, Arbeit LA (1996) Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. Clin Immunol Immunopathol 78(2):161\u2013171. https:\/\/doi.org\/10.1006\/clin.1996.0025","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"1365_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/brain\/117.1.199","volume":"117","author":"M Lauritzen","year":"1994","unstructured":"Lauritzen M (1994) Pathophysiology of the migraine aura: the spreading depression theory. Brain. 117(1):199\u2013210. https:\/\/doi.org\/10.1093\/brain\/117.1.199","journal-title":"Brain."},{"issue":"6123","key":"1365_CR25","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.1231897","volume":"339","author":"H Karatas","year":"2013","unstructured":"Karatas H, Erdener SE, Gursoy-Ozdemir Y et al (2013) Spreading depression triggers headache by activating neuronal Panx1 channels. Science 339(6123):1092\u20131095. https:\/\/doi.org\/10.1126\/science.1231897","journal-title":"Science"},{"issue":"26","key":"1365_CR26","doi-asserted-by":"publisher","first-page":"8807","DOI":"10.1523\/JNEUROSCI.0511-10.2010","volume":"30","author":"XC Zhang","year":"2010","unstructured":"Zhang XC, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R (2010) Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci 30(26):8807\u20138814. https:\/\/doi.org\/10.1523\/JNEUROSCI.0511-10.2010","journal-title":"J Neurosci"},{"issue":"5","key":"1365_CR27","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/ana.22329.Activation","volume":"69","author":"XC Zhang","year":"2011","unstructured":"Zhang XC, Levy D, Kainz V, Noseda R, Jakubowski M, Burstein R (2011) Activation of central TGV neurons by CSD. Ann Neurol 69(5):855\u2013865. https:\/\/doi.org\/10.1002\/ana.22329.Activation","journal-title":"Ann Neurol"},{"issue":"6","key":"1365_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/ana.25731","volume":"87","author":"N Hadjikhani","year":"2020","unstructured":"Hadjikhani N, Albrecht DS, Mainero C, Ichijo E, Ward N, Granziera C, Z\u00fcrcher NR, Akeju O, Bonnier G, Price J, Hooker JM, Napadow V, Nahrendorf M, Loggia ML, Moskowitz MA (2020) Extra-axial inflammatory signal in Parameninges in migraine with visual Aura. Ann Neurol 87(6):939\u2013949. https:\/\/doi.org\/10.1002\/ana.25731","journal-title":"Ann Neurol"},{"issue":"5","key":"1365_CR29","doi-asserted-by":"publisher","first-page":"e0227463","DOI":"10.1371\/journal.pone.0227463","volume":"15","author":"E Liktor-Busa","year":"2020","unstructured":"Liktor-Busa E, Blawn KT, Kellohen KL et al (2020) Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake. PLoS One 15(5):e0227463. https:\/\/doi.org\/10.1371\/journal.pone.0227463","journal-title":"PLoS One"},{"key":"1365_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/FNCOM.2020.00004","volume":"14","author":"H Ghaffari","year":"2020","unstructured":"Ghaffari H, Grant SC, Petzold LR, Harrington MG (2020) Regulation of CSF and brain tissue sodium levels by the blood-CSF and blood-brain barriers during migraine. Front Comput Neurosci 14:4. https:\/\/doi.org\/10.3389\/FNCOM.2020.00004","journal-title":"Front Comput Neurosci"},{"issue":"10283","key":"1365_CR31","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Terwindt GM, Al-Karagholi MA-M et al (2021) Migraine: disease characterisation, biomarkers, and precision medicine. Lancet 397(10283):1496\u20131504. https:\/\/doi.org\/10.1016\/S0140-6736(20)32162-0","journal-title":"Lancet"},{"issue":"8","key":"1365_CR32","doi-asserted-by":"publisher","first-page":"2118543","DOI":"10.1001\/jamanetworkopen.2021.18543","volume":"4","author":"L Pellesi","year":"2021","unstructured":"Pellesi L, Al-Karagholi MA-M et al (2021) Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches A Randomized Clinical Trial. JAMA Netw Open 4(8):2118543. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.18543","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1365_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0333102418765787","volume":"39","author":"ER Hendrikse","year":"2019","unstructured":"Hendrikse ER, Bower RL, Hay DL, Walker CS (2019) Molecular studies of CGRP and the CGRP family of peptides in the central nervous system. Cephalalgia. 39(3):403\u2013419. https:\/\/doi.org\/10.1177\/0333102418765787","journal-title":"Cephalalgia."},{"issue":"21","key":"1365_CR34","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1111\/bph.14053","volume":"175","author":"T Sundrum","year":"2017","unstructured":"Sundrum T, Walker CS (2017) Pituitary adenylate cyclase-activating polypeptide receptors in the trigeminovascular system: Implications for migraine. Br J Pharmacol 175(21):4109\u20134120","journal-title":"Br J Pharmacol"},{"issue":"5","key":"1365_CR35","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/sj.bjp.0707134","volume":"150","author":"L Edvinsson","year":"2007","unstructured":"Edvinsson L, Nilsson E, Jansen-Olesen I (2007) Inhibitory effect of BIBN4096BS, CGRP 8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol 150(5):633\u2013640. https:\/\/doi.org\/10.1038\/sj.bjp.0707134","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1365_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10194-008-0036-8","volume":"9","author":"LH Lassen","year":"2008","unstructured":"Lassen LH, Jacobsen VB, Haderslev PA, Sperling B, Iversen HK, Olesen J, Tfelt-Hansen P (2008) Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain. 9(3):151\u2013157. https:\/\/doi.org\/10.1007\/s10194-008-0036-8","journal-title":"J Headache Pain."},{"issue":"17","key":"1365_CR37","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1212\/WNL.0b013e3181f9626a","volume":"75","author":"MS Asghar","year":"2010","unstructured":"Asghar MS, Hansen AE, Kapijimpanga T, van der Geest RJ, van der Koning P, Larsson HBW, Olesen J, Ashina M (2010) Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology. 75(17):1520\u20131526. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f9626a","journal-title":"Neurology."},{"issue":"20","key":"1365_CR38","doi-asserted-by":"publisher","first-page":"e2488","DOI":"10.1212\/wnl.0000000000011930","volume":"96","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Mahdi Al-Karagholi M, Arngrim N et al (2021) Effect of Adrenomedullin on migraine-like attacks in patients with migraine. Neurology. 96(20):e2488\u2013e2499. https:\/\/doi.org\/10.1212\/wnl.0000000000011930","journal-title":"Neurology."},{"issue":"1","key":"1365_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1468-2982.2008.01695.x","volume":"29","author":"KA Petersen","year":"2009","unstructured":"Petersen KA, Birk S, Kitamura K, Olesen J (2009) Effect of adrenomedullin on the cerebral circulation: relevance to primary headache disorders. Cephalalgia. 29(1):23\u201330. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01695.x","journal-title":"Cephalalgia."},{"issue":"22","key":"1365_CR40","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/0024-3205(95)02197-Q","volume":"57","author":"WA Banks","year":"1995","unstructured":"Banks WA, Kastin AJ, Maness LM, Huang W, Jaspan JB (1995) Permeability of the blood-brain barrier to amylin. Life Sci 57(22):1993\u20132001. https:\/\/doi.org\/10.1016\/0024-3205(95)02197-Q","journal-title":"Life Sci"},{"issue":"3","key":"1365_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0196-9781(03)00059-7","volume":"24","author":"D Dogrukol-Ak","year":"2003","unstructured":"Dogrukol-Ak D, Banks WA, Tuncel N, Tuncel M (2003) Passage of vasoactive intestinal peptide across the blood-brain barrier. Peptides. 24(3):437\u2013444. https:\/\/doi.org\/10.1016\/S0196-9781(03)00059-7","journal-title":"Peptides."},{"issue":"6","key":"1365_CR42","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/ana.26072","volume":"89","author":"H Ghanizada","year":"2021","unstructured":"Ghanizada H, Al-Karagholi MAM, Walker CS et al (2021) Amylin analog Pramlintide induces migraine-like attacks in patients. Ann Neurol 89(6):1157\u20131171. https:\/\/doi.org\/10.1002\/ana.26072","journal-title":"Ann Neurol"},{"issue":"2","key":"1365_CR43","first-page":"690","volume":"267","author":"WA Banks","year":"1993","unstructured":"Banks WA, Kastin AJ, Komaki G, Arimura A (1993) Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood- brain barrier. J Pharmacol Exp Ther 267(2):690\u2013696","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"1365_CR44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0333102419864507","volume":"40","author":"H Ghanizada","year":"2020","unstructured":"Ghanizada H, Al-Karagholi MA, Arngrim N, Olesen J, Ashina M (2020) PACAP27 induces migraine-like attacks in migraine patients. Cephalalgia. 40(1):57\u201367. https:\/\/doi.org\/10.1177\/0333102419864507","journal-title":"Cephalalgia."},{"issue":"2","key":"1365_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.npep.2012.12.005","volume":"47","author":"A Erdling","year":"2013","unstructured":"Erdling A, Sheykhzade M, Maddahi A, Bari F, Edvinsson L (2013) VIP\/PACAP receptors in cerebral arteries of rat: Characterization, localization and relation to intracellular calcium. Neuropeptides 47(2):85\u201392. https:\/\/doi.org\/10.1016\/j.npep.2012.12.005","journal-title":"Neuropeptides"},{"key":"1365_CR46","doi-asserted-by":"publisher","first-page":"170134","DOI":"10.1016\/j.peptides.2019.170134","volume":"121","author":"H Ghanizada","year":"2019","unstructured":"Ghanizada H, Al-Karagholi MA, Arngrim N et al (2019) Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: a 3T MRI study. Peptides. 121:170134. https:\/\/doi.org\/10.1016\/j.peptides.2019.170134","journal-title":"Peptides."},{"issue":"1","key":"1365_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain. 132(1):16\u201325. https:\/\/doi.org\/10.1093\/brain\/awn307","journal-title":"Brain."},{"issue":"1","key":"1365_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1129-2377-15-22","volume":"15","author":"G Gr\u00e4nde","year":"2014","unstructured":"Gr\u00e4nde G, Labruijere S, Haanes KA, MaassenVanDenBrink A, Edvinsson L (2014) Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds. J Headache Pain. 15(1):22. https:\/\/doi.org\/10.1186\/1129-2377-15-22","journal-title":"J Headache Pain."},{"issue":"3","key":"1365_CR49","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/brain\/awt369","volume":"137","author":"FM Amin","year":"2014","unstructured":"Amin FM, Hougaard A, Schytz HW, Asghar MS, Lundholm E, Parvaiz AI, de Koning PJH, Andersen MR, Larsson HBW, Fahrenkrug J, Olesen J, Ashina M (2014) Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Brain. 137(3):779\u2013794. https:\/\/doi.org\/10.1093\/brain\/awt369","journal-title":"Brain."},{"issue":"1\u20132","key":"1365_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0378-5173(03)00039-5","volume":"255","author":"C Dufes","year":"2003","unstructured":"Dufes C, Olivier JC, Gaillard F, Gaillard A, Couet W, Muller JM (2003) Brain delivery of vasoactive intestinal peptide (VIP) following nasal administration to rats. Int J Pharm 255(1\u20132):87\u201397. https:\/\/doi.org\/10.1016\/S0378-5173(03)00039-5","journal-title":"Int J Pharm"},{"issue":"8","key":"1365_CR51","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/j.1468-2982.2006.01149.x","volume":"26","author":"JM Hansen","year":"2006","unstructured":"Hansen JM, Sitarz J, Birk S, Rahmann AM, Oturai PS, Fahrenkrug J, Olesen J, Ashina M (2006) Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia. 26(8):992\u20131003. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.01149.x","journal-title":"Cephalalgia."},{"issue":"3","key":"1365_CR52","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1468-2982.2007.01497.x","volume":"28","author":"A Rahmann","year":"2008","unstructured":"Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia. 28(3):226\u2013236. https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01497.x","journal-title":"Cephalalgia."},{"issue":"11","key":"1365_CR53","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1177\/0333102420937655","volume":"40","author":"L Pellesi","year":"2020","unstructured":"Pellesi L, Al-Karagholi MA, Chaudhry BA et al (2020) Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers. Cephalalgia 40(11):1223. https:\/\/doi.org\/10.1177\/0333102420937655","journal-title":"Cephalalgia"},{"issue":"12","key":"1365_CR54","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1161\/01.str.20.12.1733","volume":"20","author":"A Dahl","year":"1989","unstructured":"Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K (1989) Effect of nitroglycerin on cerebral circulation measured by transcranial Doppler and SPECT. Stroke. 20(12):1733\u20131736. https:\/\/doi.org\/10.1161\/01.str.20.12.1733","journal-title":"Stroke."},{"issue":"8","key":"1365_CR55","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1113\/EP087022","volume":"103","author":"JM Schulz","year":"2018","unstructured":"Schulz JM, Al-Khazraji BK, Shoemaker JK (2018) Sodium nitroglycerin induces middle cerebral artery vasodilatation in young, healthy adults. Exp Physiol 103(8):1047\u20131055. https:\/\/doi.org\/10.1113\/EP087022","journal-title":"Exp Physiol"},{"issue":"8","key":"1365_CR56","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1093\/brain\/awn094","volume":"131","author":"GG Schoonman","year":"2008","unstructured":"Schoonman GG, Van Der Grond J, Kortmann C, Van Der Geest RJ, Terwindt GM, Ferrari MD (2008) Migraine headache is not associated with cerebral or meningeal vasodilatation - a 3T magnetic resonance angiography study. Brain. 131(8):2192\u20132200. https:\/\/doi.org\/10.1093\/brain\/awn094","journal-title":"Brain."},{"issue":"2","key":"1365_CR57","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jnc.13454","volume":"136","author":"V G\u00f3mez-Vallejo","year":"2016","unstructured":"G\u00f3mez-Vallejo V, Ugarte A, Garc\u00eda-Barroso C, Cuadrado-Tejedor M, Szczupak B, Dopeso-Reyes IG, Lanciego JL, Garc\u00eda-Osta A, Llop J, Oyarzabal J, Franco R (2016) Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels. J Neurochem 136(2):403\u2013415. https:\/\/doi.org\/10.1111\/jnc.13454","journal-title":"J Neurochem"},{"issue":"7","key":"1365_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/j.1468-2982.2003.00712.x","volume":"24","author":"C Kruuse","year":"2003","unstructured":"Kruuse C, Frandsen E, Schifter S, Thomsen LL, Birk S, Olesen J (2003) Plasma levels of cAMP, cGMP and CGRP in sildenafil-induced headache. Cephalalgia 24(7):547\u2013553","journal-title":"Cephalalgia"},{"issue":"3","key":"1365_CR59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/0333102412468340","volume":"33","author":"G Gr\u00e4nde","year":"2013","unstructured":"Gr\u00e4nde G, Nilsson E, Edvinsson L (2013) Comparison of responses to vasoactive drugs in human and rat cerebral arteries using myography and pressurized cerebral artery method. Cephalalgia. 33(3):152\u2013159. https:\/\/doi.org\/10.1177\/0333102412468340","journal-title":"Cephalalgia."},{"issue":"2\u20133","key":"1365_CR60","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ejphar.2011.10.037","volume":"674","author":"C Kruuse","year":"2012","unstructured":"Kruuse C, Gupta S, Nilsson E, Kruse L, Edvinsson L (2012) Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries. Eur J Pharmacol 674(2\u20133):345\u2013351. https:\/\/doi.org\/10.1016\/j.ejphar.2011.10.037","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"1365_CR61","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1093\/brain\/awu244","volume":"137","author":"S Guo","year":"2014","unstructured":"Guo S, Olesen J, Ashina M (2014) Phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cyclic AMP increase. Brain. 137(11):2951\u20132959. https:\/\/doi.org\/10.1093\/brain\/awu244","journal-title":"Brain."},{"issue":"10","key":"1365_CR62","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1093\/brain\/awy228","volume":"141","author":"JH Butt","year":"2018","unstructured":"Butt JH, Rostrup E, Hansen AS, Lambertsen KL, Kruuse C (2018) Induction of migraine-like headache, but not aura, by cilostazol in patients with migraine with aura. Brain. 141(10):2943\u20132951. https:\/\/doi.org\/10.1093\/brain\/awy228","journal-title":"Brain."},{"issue":"12","key":"1365_CR63","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1097\/01.WCB.0000143536.22131.D7","volume":"24","author":"S Birk","year":"2004","unstructured":"Birk S, Kruuse C, Petersen KA, Jonassen O, Tfelt-Hansen P, Olesen J (2004) The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J Cereb Blood Flow Metab 24(12):1352\u20131358. https:\/\/doi.org\/10.1097\/01.WCB.0000143536.22131.D7","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"1365_CR64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/brain\/awy300","volume":"142","author":"S Khan","year":"2019","unstructured":"Khan S, Amin FM, Christensen CE, Ghanizada H, Younis S, Olinger ACR, de Koning PJH, Larsson HBW, Ashina M (2019) Meningeal contribution to migraine pain: a magnetic resonance angiography study. Brain. 142(1):93\u2013102. https:\/\/doi.org\/10.1093\/brain\/awy300","journal-title":"Brain."},{"issue":"9","key":"1365_CR65","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1093\/brain\/awz199","volume":"142","author":"MA Al-Karagholi","year":"2019","unstructured":"Al-Karagholi MA, Hansen JM, Guo S, Olesen J, Ashina M (2019) Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine. Brain. 142(9):2644\u20132654. https:\/\/doi.org\/10.1093\/brain\/awz199","journal-title":"Brain."},{"issue":"6","key":"1365_CR66","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1177\/0271678X20959294","volume":"41","author":"MAM Al-Karagholi","year":"2020","unstructured":"Al-Karagholi MAM, Ghanizada H, Nielsen CAW et al (2020) Cerebrovascular effects of glibenclamide investigated using high-resolution magnetic resonance imaging in healthy volunteers. J Cereb Blood Flow Metab 41(6):1328\u20131337. https:\/\/doi.org\/10.1177\/0271678X20959294","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"1365_CR67","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1097\/j.pain.0000000000002238","volume":"162","author":"MA Al-Karagholi","year":"2021","unstructured":"Al-Karagholi MA, Ghanizada H, Waldorff Nielsen CA et al (2021) Opening of BKCa channels causes migraine attacks: a new downstream target for the treatment of migraine. Pain 162(10):2512\u20132520","journal-title":"Pain"},{"issue":"11","key":"1365_CR68","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1177\/0333102420940681","volume":"40","author":"MA Al-karagholi","year":"2020","unstructured":"Al-karagholi MA, Ghanizada H, Amalie C et al (2020) Opening of BK Ca channels alters cerebral hemodynamic and causes headache in healthy volunteers. Cephalalgia 40(11):1145\u20131154. https:\/\/doi.org\/10.1177\/0333102420940681","journal-title":"Cephalalgia"},{"issue":"1","key":"1365_CR69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-2001-12621","volume":"33","author":"AJ Kastin","year":"2001","unstructured":"Kastin AJ, Akerstrom V, Hackler L, Pan W (2001) Adrenomedullin and the blood-brain barrier. Horm Metab Res 33(1):19\u201325. https:\/\/doi.org\/10.1055\/s-2001-12621","journal-title":"Horm Metab Res"},{"issue":"5","key":"1365_CR70","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0196-9781(98)00018-7","volume":"19","author":"WA Banks","year":"1998","unstructured":"Banks WA, Kastin AJ (1998) Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides. 19(5):883\u2013889. https:\/\/doi.org\/10.1016\/S0196-9781(98)00018-7","journal-title":"Peptides."},{"issue":"1","key":"1365_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-018-0861-3","volume":"19","author":"FM Amin","year":"2018","unstructured":"Amin FM, Schytz HW (2018) Transport of the pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier: implications for migraine. J Headache Pain. 19(1):35. https:\/\/doi.org\/10.1186\/s10194-018-0861-3","journal-title":"J Headache Pain."},{"issue":"3","key":"1365_CR72","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.regpep.2006.12.010","volume":"140","author":"S Birk","year":"2007","unstructured":"Birk S, Sitarz JT, Petersen KA, Oturai PS, Kruuse C, Fahrenkrug J, Olesen J (2007) The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers. Regul Pept 140(3):185\u2013191. https:\/\/doi.org\/10.1016\/j.regpep.2006.12.010","journal-title":"Regul Pept"},{"issue":"2","key":"1365_CR73","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/0333102411431333","volume":"32","author":"FM Amin","year":"2012","unstructured":"Amin FM, Asghar MS, Guo S, Hougaard A, Hansen AE, Schytz HW, van der Geest RJ, de Koning PJH, Larsson HBW, Olesen J, Ashina M (2012) Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers. Cephalalgia. 32(2):140\u2013149. https:\/\/doi.org\/10.1177\/0333102411431333","journal-title":"Cephalalgia."},{"issue":"2","key":"1365_CR74","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10194-011-0415-4","volume":"13","author":"MS Asghar","year":"2012","unstructured":"Asghar MS, Hansen AE, Larsson HBW, Olesen J, Ashina M (2012) Effect of CGRP and sumatriptan on the BOLD response in visual cortex. J Headache Pain 13(2):159\u2013166. https:\/\/doi.org\/10.1007\/s10194-011-0415-4","journal-title":"J Headache Pain"},{"key":"1365_CR75","doi-asserted-by":"publisher","first-page":"107528","DOI":"10.1016\/j.pharmthera.2020.107528","volume":"211","author":"T de Vries","year":"2020","unstructured":"de Vries T, Villal\u00f3n CM, MaassenVanDenBrink A (2020) Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans. Pharmacol Ther 211:107528. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107528","journal-title":"Pharmacol Ther"},{"issue":"2","key":"1365_CR76","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1124\/jpet.113.206458","volume":"347","author":"ED Hostetler","year":"2013","unstructured":"Hostetler ED, Joshi AD, Sanabria-Boh\u00f3rquez S, Fan H, Zeng Z, Purcell M, Gantert L, Riffel K, Williams M, O\u2019Malley S, Miller P, Selnick HG, Gallicchio SN, Bell IM, Salvatore CA, Kane SA, Li CC, Hargreaves RJ, de Groot T, Bormans G, van Hecken A, Derdelinckx I, de Hoon J, Reynders T, Declercq R, de Lepeleire I, Kennedy WP, Blanchard R, Marcantonio EE, Sur C, Cook JJ, van Laere K, Evelhoch JL (2013) In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232. J Pharmacol Exp Ther 347(2):478\u2013486. https:\/\/doi.org\/10.1124\/jpet.113.206458","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"1365_CR77","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/0333102420914913","volume":"40","author":"SL Christensen","year":"2020","unstructured":"Christensen SL, Ernstsen C, Olesen J, Kristensen DM (2020) No central action of CGRP antagonising drugs in the GTN mouse model of migraine. Cephalalgia. 40(9):924\u2013934. https:\/\/doi.org\/10.1177\/0333102420914913","journal-title":"Cephalalgia."},{"issue":"3","key":"1365_CR78","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/0333102419896760","volume":"40","author":"R Noseda","year":"2020","unstructured":"Noseda R, Schain AJ, Melo-Carrillo A, Tien J, Stratton J, Mai F, Strassman AM, Burstein R (2020) Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier. Cephalalgia. 40(3):229\u2013240. https:\/\/doi.org\/10.1177\/0333102419896760","journal-title":"Cephalalgia."},{"issue":"8","key":"1365_CR79","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/S41582-021-00509-5","volume":"17","author":"AK Eigenbrodt","year":"2021","unstructured":"Eigenbrodt AK, Ashina H, Khan S, Diener HC, Mitsikostas DD, Sinclair AJ, Pozo-Rosich P, Martelletti P, Ducros A, Lant\u00e9ri-Minet M, Braschinsky M, del Rio MS, Daniel O, \u00d6zge A, Mammadbayli A, Arons M, Skorobogatykh K, Romanenko V, Terwindt GM, Paemeleire K, Sacco S, Reuter U, Lampl C, Schytz HW, Katsarava Z, Steiner TJ, Ashina M (2021) Diagnosis and management of migraine in ten steps. Nat Rev Neurol 17(8):501\u2013514. https:\/\/doi.org\/10.1038\/S41582-021-00509-5","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"1365_CR80","doi-asserted-by":"publisher","first-page":"e2732","DOI":"10.1002\/HUP.2732","volume":"35","author":"EM Pearlman","year":"2020","unstructured":"Pearlman EM, Wilbraham D, Dennehy EB et al (2020) Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls. Hum Psychopharmacol 35(5):e2732. https:\/\/doi.org\/10.1002\/HUP.2732","journal-title":"Hum Psychopharmacol"},{"issue":"1","key":"1365_CR81","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/S10194-020-01132-3","volume":"21","author":"DB Clemow","year":"2020","unstructured":"Clemow DB, Johnson KW, Hochstetler HM et al (2020) Lasmiditan mechanism of action - review of a selective 5-HT 1F agonist. J Headache Pain 21(1):71. https:\/\/doi.org\/10.1186\/S10194-020-01132-3","journal-title":"J Headache Pain"},{"issue":"2","key":"1365_CR82","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/J.NEURON.2014.12.032","volume":"85","author":"A Montagne","year":"2015","unstructured":"Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV (2015) Blood-brain barrier breakdown in the aging human Hippocampus. Neuron. 85(2):296\u2013302. https:\/\/doi.org\/10.1016\/J.NEURON.2014.12.032","journal-title":"Neuron."},{"issue":"2","key":"1365_CR83","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/S41591-018-0297-Y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Chui HC, Law M, Toga AW, Zlokovic BV (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25(2):270\u2013276. https:\/\/doi.org\/10.1038\/S41591-018-0297-Y","journal-title":"Nat Med"},{"issue":"3","key":"1365_CR84","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.pain.2004.05.007","volume":"110","author":"SK Afridi","year":"2004","unstructured":"Afridi SK, Kaube H, Goadsby PJ (2004) Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain. 110(3):675\u2013680. https:\/\/doi.org\/10.1016\/j.pain.2004.05.007","journal-title":"Pain."},{"issue":"Pt 1","key":"1365_CR85","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/brain\/awt320","volume":"137","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ (2014) Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 137(Pt 1):232\u2013241. https:\/\/doi.org\/10.1093\/brain\/awt320","journal-title":"Brain."},{"issue":"12","key":"1365_CR86","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1097\/j.pain.0000000000000702","volume":"157","author":"S Guo","year":"2016","unstructured":"Guo S, Vollesen ALH, Olesen J, Ashina M (2016) Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine. Pain. 157(12):2773\u20132781. https:\/\/doi.org\/10.1097\/j.pain.0000000000000702","journal-title":"Pain."},{"issue":"8","key":"1365_CR87","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/brain\/awab136","volume":"2021","author":"MA-M Al-Karagholi","year":"2021","unstructured":"Al-Karagholi MA-M, Ghanizada H, Nielsen CAW, Hougaard A, Ashina M (2021) Opening of ATP sensitive potassium channels causes migraine attacks with aura. Brain. 2021(8):2322\u20132332. https:\/\/doi.org\/10.1093\/brain\/awab136","journal-title":"Brain."},{"issue":"5","key":"1365_CR88","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00004647-200205000-00014","volume":"22","author":"KR Oliver","year":"2002","unstructured":"Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG (2002) Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 22(5):620\u2013629. https:\/\/doi.org\/10.1097\/00004647-200205000-00014","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"1365_CR89","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/cne.21607","volume":"507","author":"JK Lennerz","year":"2008","unstructured":"Lennerz JK, R\u00fchle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507(3):1277\u20131299. https:\/\/doi.org\/10.1002\/cne.21607","journal-title":"J Comp Neurol"},{"issue":"1","key":"1365_CR90","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s10194-019-1055-3","volume":"20","author":"JCA Edvinsson","year":"2019","unstructured":"Edvinsson JCA, Warfvinge K, Krause DN, Blixt FW, Sheykhzade M, Edvinsson L, Haanes KA (2019) C-fibers may modulate adjacent A\u03b4-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system. J Headache Pain. 20(1):105. https:\/\/doi.org\/10.1186\/s10194-019-1055-3","journal-title":"J Headache Pain."},{"issue":"6","key":"1365_CR91","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/acn3.197","volume":"2","author":"CS Walker","year":"2015","unstructured":"Walker CS, Eftekhari S, Bower RL, Wilderman A, Insel PA, Edvinsson L, Waldvogel HJ, Jamaluddin MA, Russo AF, Hay DL (2015) A second trigeminal CGRP receptor: function and expression of the AMY<inf>1<\/inf> receptor. Ann Clin Transl Neurol 2(6):595\u2013608. https:\/\/doi.org\/10.1002\/acn3.197","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"1365_CR92","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1073\/pnas.82.1.248","volume":"82","author":"FA Tschopp","year":"1985","unstructured":"Tschopp FA, Henke H, Petermann JB, Tobler PH, Janzer R, Hokfelt T, Lundberg JM, Cuello C, Fischer JA (1985) Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc Natl Acad Sci U S A 82(1):248\u2013252. https:\/\/doi.org\/10.1073\/pnas.82.1.248","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1365_CR93","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1046\/j.1365-2826.2003.01064.x","volume":"15","author":"TJE Stachniak","year":"2003","unstructured":"Stachniak TJE, Krukoff TL (2003) Receptor activity modifying protein 2 distribution in the rat central nervous system and regulation by changes in blood pressure. J Neuroendocrinol 15(9):840\u2013850. https:\/\/doi.org\/10.1046\/j.1365-2826.2003.01064.x","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"1365_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102418821621","volume":"39","author":"K Hensley","year":"2018","unstructured":"Hensley K, Pretorius J, Chan B (2018) PAC1 receptor mRNA and protein distribution in rat and human trigeminal and sphenopalatine ganglia, spinal trigeminal nucleus and in dura mater. Cephalalgia 39(7):1\u201314. https:\/\/doi.org\/10.1177\/0333102418821621","journal-title":"Cephalalgia"},{"issue":"2","key":"1365_CR95","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.npep.2014.01.004","volume":"48","author":"I Jansen-Olesen","year":"2014","unstructured":"Jansen-Olesen I, Baun M, Amrutkar DV, Ramachandran R, Christophersen DV, Olesen J (2014) PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor. Neuropeptides. 48(2):53\u201364. https:\/\/doi.org\/10.1016\/j.npep.2014.01.004","journal-title":"Neuropeptides."},{"issue":"2","key":"1365_CR96","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.neuroscience.2009.02.028","volume":"160","author":"V Jolivel","year":"2009","unstructured":"Jolivel V, Basille M, Aubert N, de Jouffrey S, Ancian P, le Bigot JF, Noack P, Massonneau M, Fournier A, Vaudry H, Gonzalez BJ, Vaudry D (2009) Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Neuroscience. 160(2):434\u2013451. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.02.028","journal-title":"Neuroscience."},{"issue":"4","key":"1365_CR97","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/cne.20231","volume":"476","author":"KM Joo","year":"2004","unstructured":"Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI (2004) Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol 476(4):388\u2013413. https:\/\/doi.org\/10.1002\/cne.20231","journal-title":"J Comp Neurol"},{"issue":"1\u20133","key":"1365_CR98","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2008.10.041","volume":"601","author":"KB Ploug","year":"2008","unstructured":"Ploug KB, S\u00f8rensen MA, Str\u00f8bech L, Klaerke DA, Hay-Schmidt A, Sheykhzade M, Olesen J, Jansen-Olesen I (2008) KATP channels in pig and human intracranial arteries. Eur J Pharmacol 601(1\u20133):43\u201349. https:\/\/doi.org\/10.1016\/j.ejphar.2008.10.041","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1365_CR99","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/bjp.2008.86","volume":"154","author":"KB Ploug","year":"2008","unstructured":"Ploug KB, Boni LJ, Baun M, Hay-Schmidt A, Olesen J, Jansen-Olesen I (2008) K ATP channel expression and pharmacological in vivo and in vitro studies of the K ATP channel blocker PNU-37883A in rat middle meningeal arteries. Br J Pharmacol 154(1):72\u201381. https:\/\/doi.org\/10.1038\/bjp.2008.86","journal-title":"Br J Pharmacol"},{"key":"1365_CR100","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/jid.2014.371","volume":"80","author":"K Nui","year":"2011","unstructured":"Nui K, Saloman JL, Zhang Y, Ro JY (2011) Sex diffferences in the contribution of ATP-sensitive K+ channels in trigeminal ganglia under an acute muscle pain condition. Neuroscience 80:344\u2013352. https:\/\/doi.org\/10.1038\/jid.2014.371","journal-title":"Neuroscience"},{"issue":"1","key":"1365_CR101","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/0333102411430266","volume":"32","author":"KB Ploug","year":"2012","unstructured":"Ploug KB, Amrutkar DV, Baun M, Ramachandran R, Iversen A, Lund TM, Gupta S, Hay-Schmidt A, Olesen J, Jansen-Olesen I (2012) K ATP channel openers in the trigeminovascular system. Cephalalgia. 32(1):55\u201365. https:\/\/doi.org\/10.1177\/0333102411430266","journal-title":"Cephalalgia."},{"issue":"1\u20132","key":"1365_CR102","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0006-8993(98)00956-1","volume":"814","author":"AA Dunn-Meynell","year":"1998","unstructured":"Dunn-Meynell AA, Rawson NE, Levin BE (1998) Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain. Brain Res 814(1\u20132):41\u201354. https:\/\/doi.org\/10.1016\/S0006-8993(98)00956-1","journal-title":"Brain Res"},{"issue":"6","key":"1365_CR103","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00418-005-0124-7","volume":"125","author":"U Sausbier","year":"2006","unstructured":"Sausbier U, Sausbier M, Sailer CA, Arntz C, Knaus HG, Neuhuber W, Ruth P (2006) Ca2+\u2212activated K+ channels of the BK-type in the mouse brain. Histochem Cell Biol 125(6):725\u2013741. https:\/\/doi.org\/10.1007\/s00418-005-0124-7","journal-title":"Histochem Cell Biol"},{"issue":"4","key":"1365_CR104","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.neuroscience.2010.02.063","volume":"167","author":"H Wulf-Johansson","year":"2010","unstructured":"Wulf-Johansson H, Amrutkar DV, Hay-Schmidt A, Poulsen AN, Klaerke DA, Olesen J, Jansen-Olesen I (2010) Localization of large conductance calcium-activated potassium channels and their effect on calcitonin gene-related peptide release in the rat trigemino-neuronal pathway. Neuroscience. 167(4):1091\u20131102. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.02.063","journal-title":"Neuroscience."},{"issue":"2","key":"1365_CR105","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.bbamem.2008.10.001","volume":"1788","author":"AN Poulsen","year":"2009","unstructured":"Poulsen AN, Wulf H, Hay-Schmidt A, Jansen-Olesen I, Olesen J, Klaerke DA (2009) Differential expression of BK channel isoforms and \u03b2-subunits in rat neuro-vascular tissues. Biochim Biophys Acta Biomembr 1788(2):380\u2013389. https:\/\/doi.org\/10.1016\/j.bbamem.2008.10.001","journal-title":"Biochim Biophys Acta Biomembr"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01365-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-021-01365-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01365-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T08:43:45Z","timestamp":1700124225000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-021-01365-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1365"],"URL":"https:\/\/doi.org\/10.1186\/s10194-021-01365-w","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.W., H.A., N.H., A. S, B. Z and M. L all declare that they have no competing interests. M.A. is a consultant, speaker, or scientific advisor for AbbVie, Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, and Teva and a primary investigator for ongoing AbbVie\/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, and Teva trials. M.A. has no ownership interest and does not own stocks of any pharmaceutical company. M.A. serves as associate editor of Cephalalgia, associate editor of the Journal of Headache and Pain, and associate editor of Brain.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}